Cancer therapy-induced left ventricular dysfunction: Interventions and prognosis

Journal of Cardiac Failure

Volumn 20, Issue 3, 2014, Pages 155-158

  Thakur, Akanksha ^a   Witteles, Ronald M ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy; Cardiotoxicity; chemotherapy

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTHRACYCLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LOOP DIURETIC AGENT; NITRATE; PROTEIN TYROSINE KINASE INHIBITOR; THIAZIDE DIURETIC AGENT; TRASTUZUMAB; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER THERAPY; CANCER THERAPY INDUCED LEFT VENTRICULAR DYSFUNCTION; CARDIAC IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; DISEASE COURSE; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PRIORITY JOURNAL; PROGNOSIS; AGED; CHEMICALLY INDUCED; COHORT ANALYSIS; DIAGNOSIS; DRUG THERAPY; EARLY INTERVENTION; HEART LEFT VENTRICLE FUNCTION; NEOPLASMS; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR AGENTS; COHORT STUDIES; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84896078541     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.12.018     Document Type: Article

References (21)

1. E.T. Yeh, C.L. Bickford, and M.S. Ewer The diagnosis and management of cardiovascular disease in patients with cancer V. Fuster, R.A. Walsh, R.A. Harrington, Hurst's the heart 13th ed. 2011 McGraw-Hill New York Chapter 90. Available at: http://www.accessmedicine.com/content.aspx?aID=7831749 Accessed August 12, 2013
2. E.C. van Dalen, H.N. Caron, H.O. Dickinson, and L.C. Kremer Cardioprotective Interventions for cancer patients receiving anthracyclines Cochrane Database Syst Rev 2008 CD003917
3. P.S. Hall, L.C. Harshman, S. Srinivas, and R.M. Witteles The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients J Am Coll Cardiol Heart Fail 1 2013 72 78
4. M. Ryberg, D. Nielsen, T. Skovsgaard, J. Hansen, B.V. Jensen, and P. Dombernowsky Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer J Clin Onc 16 1998 3502 3508
5. D.D. von Hoff, M.W. Layard, P. Basa, H.L. Davis Jr., A.L. von Hoff, and M. Rozencweig et al. Risk factors for doxorubicin-induced congestive heart failure Am J Med 62 1977 200 208
6. S.M. Swain, F.S. Whaley, and M.S. Ewer Congestive heart failure in patients treated with doxorubicin. A retrospective analysis of three trials Cancer 97 2003 2869 2879
7. D. Cardinale, M.T. Sandri, A. Colombo, N. Colombo, M. Boeri, and G. Lamantia et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 109 2004 2749 2754
8. D. Cardinale, A. Colombo, R. Torrisi, M.T. Sandri, M. Civelli, and M. Salvatici et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation J Clin Oncol 28 2010 3910 3916
9. H. Nakamae, K. Tsumura, Y. Terada, T. Nakane, M. Nakamae, and K. Ohta et al. Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone Cancer 104 2005 2492 2498
10. J.M. Horacek, R. Pudil, L. Jebavy, M. Tichy, P. Zak, and J. Maly Assessment of anthracycline-induced cardiotoxicity with biochemical markers Exp Oncol 29 2007 309 313
11. Q.S. Wells, and D.J. Lenihan Reversibility of left ventricular dysfunction resulting from chemotherapy: can this be expected? Prog Cardiovasc Dis 53 2010 140 148
12. C. Cadeddu, A. Piras, G. Mantovani, M. Deidda, M. Dessl, and C. Madeddu et al. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment Am Heart J 160 2010 487.e1-7
13. D. Cardinale, M.T. Sandri, A. Martinoni, A. Tricca, M. Civelli, and G. Lamantia et al. Left ventricular dysfunction predicted by early troponin i release after high-dose chemotherapy J Am Coll Cardiol 36 2000 517 522
14. D. Cardinale, M.T. Sandri, A. Martinoni, E. Borghini, M. Civelli, and G. Lamantia et al. Myocardial injury revealed by plasma troponin i in breast cancer treated with high-dose chemotherapy Ann Oncol 13 2002 710 715
15. P. Georgakopoulos, P. Roussou, E. Matsakas, A. Karavidas, N. Anagnostopoulos, and T. Marinakis et al. Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up Am J Hematol 85 2010 894 896
16. B.V. Jensen, T. Skovsgaard, and S.L. Nielsen Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients Ann Oncol 13 2002 699 709
17. N. Kalay, E. Basar, I. Ozdogru, O. Er, Y. Cetinkaya, and A. Dogan et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy J Am Coll Cardiol 48 2006 2258 2262
18. X. Bosch, M. Rovira, M. Sitges, A. Domenech, J.T. Ortiz-Perez, and T.M. de Caralt et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies J Am Coll Cardiol 61 2013 2355 2362
19. A. Noori, J. Lindenfeld, E. Wolfel, D. Ferguson, M.R. Bristow, and B.D. Lowes Beta-blockade in adriamycin-induced cardiomyopathy J Card Fail 6 2000 115 119
20. G. Specchia, C. Buquicchio, N. Pansini, F. di Serio, V. Liso, and D. Pastore et al. Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines J Lab Clin Med 145 2005 212 220
21. D. Cardinale, A. Colombo, M.T. Sandri, G. Lamantia, N. Colombo, and M. Civelli et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition Circulation 114 2006 2474 2481